The majority of the human brain is not yet fully understood and we still have a lot to learn about its workings. A group of scientists have performed a comprehensive first characterization of the human occipital lobe (primary visual cortex) and cerebellum proteomes from 12 post-mortem samples.
The majority of the human brain is not yet fully understood and we still have a lot to learn about its workings. A group of scientists have performed a comprehensive first characterization of the human occipital lobe (primary visual cortex) and cerebellum proteomes from 12 post-mortem samples.1 Proteins were identified using gel electrophoresis combined with data-independent nanoflow liquid chromatography mass spectrometry (nLC–MSE). The resulting data sets comprised 391 and 330 unique proteins in occipital lobe and cerebellum, respectively, present in at least 75% of the analysed samples with 297 proteins found in common. The majority of these proteins have been identified with cellular and neuronal functions and subsequently with conditions, such as neurological disorder, progressive motor neuropathy, Parkinson’s disease and schizophrenia.
Of most note was the discovery of growth hormone and several examples of Ca2+ dependent calmodulin kinase and serine/threonine protein phosphatase in the occipital lobe. This raises the possibility that growth hormone could potentially play a part in visual processing. More research needs to be performed to identify whether these brain proteomes could help in the clarification of neurological processes and pinpoint potential targets for therapeutic strategies.
1. S. Bahn et al., Proteomics, 12(3), 500–504 (2012).
This story originally appeared in The Column. Click here to view that issue.
An LC–HRMS Method for Separation and Identification of Hemoglobin Variant Subunits
March 6th 2025Researchers from Stanford University’s School of Medicine and Stanford Health Care report the development of a liquid chromatography high-resolution mass spectrometry (LC–HRMS) method for identifying hemoglobin (Hb) variants. The method can effectively separate several pairs of normal and variant Hb subunits with mass shifts of less than 1 Da and accurately identify them in intact-protein and top-down analyses.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.